Picture of Standard BioTools logo

LAB — Standard BioTools News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Standard BioTools Inc reports results for the quarter ended in September 30 - Earnings Summary

* Standard BioTools Inc  LAB.OQ  reported a quarterly
adjusted
loss of 7 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -27 cents.  The mean expectation of
three analysts for the quarter was for a loss of 9 cents per
share. Wall Street expected results to range from -10 cents
to -8 cents per share.
    * Revenue rose 77.3% to $44.97 million from a year ago;
analysts
expected $41.00 million. 
    * Standard BioTools Inc's reported EPS for the quarter was a
loss
of 7 cents​.
    * The company reported a quarterly loss of $26.94 million.
    * Standard BioTools Inc shares had fallen by 9.3% this
quarter and
lost 20.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 3.8%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is  "buy."

Wall Street's median 12-month price target for Standard BioTools
Inc is 2.75 
This summary was machine generated from LSEG data October 31 at
02:36 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.09          -0.07          Beat
 Jun. 30 2024      -0.08          -0.12          Missed
 Mar. 31 2024      -0.11          -0.27          Missed
 Dec. 31 2023      -0.13          -0.25          Missed

Recent news on Standard BioTools

See all news